Products
PRIMARY ANTIBODY
SECONDARY ANTIBODY
PROTEIN & PEPTIDES
BIOCHEMICALS
ASSAY & ELISA KITS
LOADING CONTROL
OTHER REAGENTS
SERUMS
CELL LINE
Contact Us
About Us
Login
Register
|
Forgot Password
Sign In
Forgot your Password?
If you've forgotten your password, enter your e-mail address below and we'll send you instructions on how to securely change your password.
Back
Continue
0
Shopping Cart
Products
Contact Us
About Us
Shopping Cart
Loading....
Login Account
Sign In
Register
Register
|
Forgot Password
Sign In
Forgot your Password?
If you've forgotten your password, enter your e-mail address below and we'll send you instructions on how to securely change your password.
Back
Continue
0
Shopping Cart
Home
BioChemicals
SB 216763
tcsc0139
SB 216763
Order Now
AVAILABLE SIZES
5mg
10mg
50mg
100mg
$
86.00
Add to Cart
ORDERING INFORMATION
International
TAICLONE BIOTECH CORP.
order@taiclone.com
+886-2-2735-9682
+886-2-2735-9807
Data sheet
Download PDF Datasheet
Technical Inquries
Submit Review
Submit Review
Please choose your application, enter the information requested below. * Marked fields are mandatory.
Full Name
Email
Contact Number
Application
Please Select..
Western blot (WB)
Immunohistochemistry (IHC)
Immunofluorescence (IF)
Immunocytochemistry (ICC)
Immunoprecipitation (IP)
Co-Immunoprecipitation (CoIP)
Chromatin Immunoprecipitation (ChIP)
RNA Binding Protein Immunoprecipitation (RIP)
Sample
Loading Amount
Loading Type
UG
CELLS
Treatment
Temperature
Exposure
Observe Band
Fixative
Select One
Acetone
Formaldehyde
Methanol
Paraformaldehyde
Other
Antigen Retrieval
Select One
Heat mediated
Enzymatic
Other
None
Positive Control
Negative Control
Dilution *
1:
Incubation Time *
Select Image *
Choose a file...
Rating *
Remarks *
Submit Review
Product Description
SB 216763 is potent and selective and ATP-competitive
glycogen synthase kinase-3 (GSK-3)
inhibitor, with an
IC
50
value of 34.3 nM for GSK-3α and GSK-3β, respectively.
IC50 & Target: IC50: 34.3 nM (GSK-3α), 34.3 nM (GSK-3β)
[5]
In Vitro:
SB-216763 (10-20 µM) induces β-catenin mediated-transcription in a dose-dependent manner in HEK293 cells. SB-216763 (10, 15 and 20 µM) can maintain mESCs with a pluripotent-like morphology in long-term culture. SB-216763 (10 µM) can maintain J1 mESCs in a pluripotent state for more than a month
[2]
. SB-216763 inhibits GSK-3 with IC
50
of 34 nM
[3]
. SB-216763 is equally effective at inhibiting human GSK-3α and GSK-3β
[5]
.
In Vivo:
SB216763 (20 mg/kg, i.v.) significantly improves the survival of BLM-treated mice. Mice randomized to receive BLM plus SB216763 shows a noteworthy reduction, compared with BLM-treated mice. SB216763 (20 mg/kg, i.v.) reduces the magnitude of BLM-induced alveolitis
[1]
. SB 216763 (0.2 mg/kg, i.v.) with either 17β-E
100
or Geni
100
reverses the ceiling effect because these agents significantly reduce infarct size when the rabbits' hearts are submitted to 30-min CAO
[4]
.
Information
CAS No
280744-09-4
Formula
C
19
H
12
Cl
2
N
2
O
2
Clinical Information
clinicalinformation
Pathway
Stem Cell/Wnt
PI3K/Akt/mTOR
Autophagy
Target
GSK-3
GSK-3
Autophagy
Specifications
Purity / Grade
>98%
Solubility
H2O : < 0.1 mg/mL (insoluble)
Smiles
smiles
Misc Information
Observed Molecular Weight
371.22
related data
Get valuable resources and offers directly to your email.
REGISTER NOW